Delivery Order SPE2DB25D3007-SPE2DB25FWSSH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors, valued at $22,549.80 under a firm fixed-price contract type. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive set-aside delivery order. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,384.18 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors. This firm fixed-price delivery order, issued on September 3, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency awarded a $9,251.06 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $2,665.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen injectors on August 13, 2025, with completion scheduled for August 14, 2025. This award was not set-aside and was competitively awarded to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $81.6K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,834.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside competitive award will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,652.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- SPE2DB25D3007Indefinite Delivery Contract
- SPE2DB25D3007-SPE2DB25FWSSHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,172.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order for Mounjaro—a diabetes medication—aligns with AmerisourceBergen's established role as a primary pharmaceutical supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive DLA contract vehicle, which enables flexible and responsive fulfillment of federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/26/25 |